Role of Gas6 in erythropoiesis and anemia in mice.

Many patients with anemia fail to respond to treatment with erythropoietin (Epo), a commonly used hormone that stimulates erythroid progenitor production and maturation by human BM or by murine spleen. The protein product of growth arrest-specific gene 6 (Gas6) is important for cell survival across several cell types, but its precise physiological role remains largely enigmatic. Here, we report that murine erythroblasts released Gas6 in response to Epo and that Gas6 enhanced Epo receptor signaling by activating the serine-threonine kinase Akt in these cells. In the absence of Gas6, erythroid progenitors and erythroblasts were hyporesponsive to the survival activity of Epo and failed to restore hematocrit levels in response to anemia. In addition, Gas6 may influence erythropoiesis via paracrine erythroblast-independent mechanisms involving macrophages. When mice with acute anemia were treated with Gas6, the protein normalized hematocrit levels without causing undesired erythrocytosis. In a transgenic mouse model of chronic anemia caused by insufficient Epo production, Gas6 synergized with Epo in restoring hematocrit levels. These findings may have implications for the treatment of patients with anemia who fail to adequately respond to Epo.

[1]  S. Yamanaka,et al.  Role of the phosphoinositide 3-kinase pathway in mouse embryonic stem (ES) cells. , 2005, Biochemical Society transactions.

[2]  S. Goff,et al.  Tyro-3 family receptors are essential regulators of mammalian spermatogenesis , 1999, Nature.

[3]  T. Honjo,et al.  High Pathogenic Potential of Low-Affinity Autoantibodies in Experimental Autoimmune Hemolytic Anemia , 1999, The Journal of experimental medicine.

[4]  B. Dahlbäck,et al.  Gas6 and protein S , 2006, The FEBS journal.

[5]  W. Sibbald,et al.  Tissue oxygen delivery and the microcirculation. , 2004, Critical care clinics.

[6]  F. Kuypers,et al.  Altered red cell turnover in diabetic mice. , 2002, The Journal of laboratory and clinical medicine.

[7]  P. Ratcliffe,et al.  Identification of the renal erythropoietin-producing cells using transgenic mice. , 1993, Kidney international.

[8]  L. Gammaitoni,et al.  GAS6, the ligand of Axl and Rse receptors, is expressed in hematopoietic tissue but lacks mitogenic activity. , 1997, Experimental hematology.

[9]  A. Wickrema,et al.  Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells). , 1999, Blood.

[10]  P. Carmeliet,et al.  Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy. , 2005, The Journal of clinical investigation.

[11]  D. Barber,et al.  Turning cells red: signal transduction mediated by erythropoietin. , 2005, Trends in cell biology.

[12]  S. Jain,et al.  Studies on lipids of red blood cells in phenylhydrazine-treated albino rats. , 1976, Indian journal of biochemistry & biophysics.

[13]  J. Chasis.  Erythroblastic islands: specialized microenvironmental niches for erythropoiesis , 2006, Current opinion in hematology.

[14]  H. Hanafusa,et al.  Identification of the Product of Growth Arrest-specific Gene 6 as a Common Ligand for Axl, Sky, and Mer Receptor Tyrosine Kinases* , 1996, The Journal of Biological Chemistry.

[15]  M. Obinata,et al.  Roles for integrin very late activation antigen-4 in stroma-dependent erythropoiesis. , 1994, Blood.

[16]  S. Yan.  Review of conformation-specific affinity purification methods for plasma vitamin K-dependent proteins. , 1996, Journal of molecular recognition : JMR.

[17]  H. Lodish,et al.  Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[18]  P. Carmeliet,et al.  Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis , 2001, Nature Medicine.

[19]  G. Schwarzer,et al.  Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis. , 2005, Journal of the National Cancer Institute.

[20]  H. Papadaki,et al.  Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect. , 2002, Blood.

[21]  P. Frenette,et al.  PSGL-1 participates in E-selectin-mediated progenitor homing to bone marrow: evidence for cooperation between E-selectin ligands and alpha4 integrin. , 2003, Blood.

[22]  N. Piva,et al.  A randomized double‐blind placebo‐controlled study with subcutaneous recombinant human erythropoietin in patients with low‐risk myelodysplastic syndromes , 1998, British journal of haematology.

[23]  H. Yamane,et al.  Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6 , 1995, Nature.

[24]  K. Okumura,et al.  A critical role of VLA-4 in erythropoiesis in vivo. , 1996, Blood.

[25]  T. Koike,et al.  Phosphatidylinositol 3-kinase is involved in the protection of primary cultured human erythroid precursor cells from apoptosis. , 1999, Blood.

[26]  C. Lacombe.  Resistance to erythropoietin. , 1996, The New England journal of medicine.

[27]  M. Blostein,et al.  The role of γ‐carboxylation in the anti‐apoptotic function of gas6 , 2005, Journal of thrombosis and haemostasis : JTH.

[28]  J. Adamson,et al.  Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. , 1987, The New England journal of medicine.

[29]  J. Charles Jennette,et al.  Delayed Apoptotic Cell Clearance and Lupus-like Autoimmunity in Mice Lacking the c-mer Membrane Tyrosine Kinase , 2002, The Journal of experimental medicine.

[30]  B. Dahlbäck,et al.  Ligand Recognition and Homophilic Interactions in Tyro3 , 2004, Journal of Biological Chemistry.

[31]  D. Weatherall,et al.  Red cells I: inherited anaemias , 2000, The Lancet.

[32]  H. Lodish,et al.  A fibronectin matrix is required for differentiation of murine erythroleukemia cells into reticulocytes , 1987, The Journal of cell biology.

[33]  H. Snodgrass,et al.  Cloning and developmental expression analysis of the murine c-mer tyrosine kinase. , 1995, Oncogene.

[34]  D. Bodine,et al.  The Dtk receptor tyrosine kinase, which binds protein S, is expressed during hematopoiesis. , 1996, Experimental hematology.

[35]  E. Ruaro,et al.  Gas6-mediated survival in NIH3T3 cells activates stress signalling cascade and is independent of Ras , 1999, Oncogene.

[36]  Qingxian Lu,et al.  Macrophage regulation by Tyro 3 family receptors. , 2003, Current opinion in immunology.

[37]  Rudolf Jaenisch,et al.  Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor , 1995, Cell.

[38]  Patrick Aebischer,et al.  Delivery of erythropoietin by encapsulated myoblasts in a genetic model of severe anemia. , 2002, Kidney international.

[39]  E. Ruaro,et al.  Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts. , 1996, Oncogene.

[40]  K. Ohashi,et al.  Cell Adhesion to Phosphatidylserine Mediated by a Product of Growth Arrest-specific Gene 6* , 1997, The Journal of Biological Chemistry.

[41]  C. Lacombe,et al.  Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation. , 2003, Blood.

[42]  F. Locatelli,et al.  Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[43]  C. Winearls,et al.  EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSIS , 1986, The Lancet.

[44]  L. Goodnough,et al.  Anemia of chronic disease. , 2005, The New England journal of medicine.

[45]  H. Nakauchi,et al.  Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival. , 1991, Cancer research.

[46]  M. Koury,et al.  Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. , 1990, Science.

[47]  F. Saller,et al.  Role of the growth arrest-specific gene 6 (gas6) product in thrombus stabilization. , 2006, Blood cells, molecules & diseases.

[48]  R. Scott,et al.  Phagocytosis and clearance of apoptotic cells is mediated by MER , 2001, Nature.

[49]  D. Huhn,et al.  Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis. , 1994, Blood.

[50]  F. Costantini,et al.  Increased susceptibility in Hp knockout mice during acute hemolysis. , 1998, Blood.

[51]  X. Zhang,et al.  Hematopoietic progenitor cells grow on 3T3 fibroblast monolayers that overexpress growth arrest-specific gene-6 (GAS6). , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[52]  C. Schneider,et al.  The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade , 1993, Molecular and cellular biology.

[53]  G. Krystal.  A simple microassay for erythropoietin based on 3H-thymidine incorporation into spleen cells from phenylhydrazine treated mice. , 1983, Experimental hematology.